William Romov

William Romov is an analyst for Investing Daily. William holds a B.B.A. in Finance from James Madison University.

Recent Articles By The Author

2 Undervalued Stocks That Will Bounce Back in 2017

2 Undervalued Stocks That Will Bounce Back in 2017

These two consumer goods companies are trading at a discount to their future earnings.

Why These 2 Undervalued Technology Stocks Are Set to Bounce Back

Why These 2 Undervalued Technology Stocks Are Set to Bounce Back

Shares of Cray Research and Inteliquent have been unfairly oversold this year and offer a great opportunity to buy in at a bargain.

2 Automotive Stocks to Buy Following Tesla's Self-Driving Upgrade Announcement

2 Automotive Stocks to Buy Following Tesla's Self-Driving Upgrade Announcement

Ford (F) and General Motors (GM) are working on their own self-driving technologies.

Here's Why These 3 Cheap Marijuana Stocks May Quadruple in Price

Here's Why These 3 Cheap Marijuana Stocks May Quadruple in Price

Shares of these cannabis companies are ready for huge growth if November is a successful month for legalization.

The 2 Best Airline Stocks to Add to Your Portfolio

The 2 Best Airline Stocks to Add to Your Portfolio

JetBlue (JBLU) and Alaska Air (ALK) offer the best combination of low pricing and an enjoyable flying experience.

2 Undervalued Cruise Line Stocks for a Portfolio

2 Undervalued Cruise Line Stocks for a Portfolio

Royal Caribbean Cruises (RCL) and Carnival (CCL) are cheap and pay solid dividends.

2 Inexpensive Marijuana Stocks That Could Quadruple in Price

2 Inexpensive Marijuana Stocks That Could Quadruple in Price

These marijuana stocks are ready for huge growth, particularly if November is a successful month for legalization.

3 Bargain Blue Chips With Dividend Yields of More Than 4.5%

3 Bargain Blue Chips With Dividend Yields of More Than 4.5%

The three big-name companies trade at a bargain compared to their peer groups.

3 Marijuana Stocks That Could Triple From Legalized Pot

3 Marijuana Stocks That Could Triple From Legalized Pot

Here are three landscaping and garden supply companies that stand to benefit big time from legal weed.

GlaxoSmithKline Vaccines for Malaria, Zika Make It a Likely Winner

GlaxoSmithKline Vaccines for Malaria, Zika Make It a Likely Winner

This pharmaceutical giant has struggled in recent years but is wisely repositioning itself as the world's largest manufacturer of vaccines.